Trigger Point Therapy
Trigger Point Therapy (Myofascial Trigger Point Release, Dry Needling, Ischemic Compression)
Evidence grade varies by use. See the breakdown on the entry. Read how the Atlas grades evidence.
Honest summary: the clinical syndrome of regional myofascial pain is real and clinically useful, and treatments aimed at tender muscle points (manual release, ischemic compression, dry needling) show modest, mostly short-term reductions in pain in randomized trials. Evidence is weakened by three persistent problems. First, there is no accepted reference standard for diagnosing a trigger point, and systematic reviews find that inter-rater reliability for locating one by palpation is poor and varies widely, so studies may not be measuring the same thing. Second, dry needling is the most-studied technique and the 2024-2025 systematic reviews find it can reduce pain and stiffness in the short term but do not establish that it is superior to other non-pharmacological options, with several outcomes inconclusive or favoring controls. Third, the entity being treated is itself contested, which caps how strong the supporting evidence can be. grade 2 reflects limited and preliminary support for short-term symptom relief, not confirmation of the underlying model.
Reference only. Not medical advice.
| Treatment | Grade | Notes |
|---|---|---|
| Short-term pain relief in regional/myofascial pain (manual or needle) | 2 of 5 | Multiple RCTs and 2024-2025 meta-analyses show modest short-term benefit; superiority over other treatments not established and reliability of the target is poor. |
| Chronic neck and shoulder myofascial pain (dry needling) | 2 of 5 | Most-studied area; pain and stiffness improve short term, but effects fade and several outcomes are inconclusive or favor controls. |
| Existence of 'trigger points' as discrete, reliably identifiable physical lesions | 1 of 5 | Theory and clinical tradition outpace evidence; no reference standard, palpation reliability poor, mechanism contested. |
| Long-term or curative resolution of chronic pain conditions | 1 of 5 | Durable benefit beyond short follow-up is not demonstrated in controlled trials. |
What can go wrong
Generally low risk in trained hands. Manual pressure and ischemic compression can cause transient soreness or bruising. Dry needling carries the added risks of any skin-penetrating procedure: bleeding, bruising, fainting, infection if technique is poor, and, rarely but seriously, pneumothorax (lung puncture) when needling over the chest wall, shoulder girdle, or upper back. Choosing trigger point work in place of evaluation for pain that may have another cause (nerve compression, inflammatory, vascular, or referred visceral pain) is the larger practical risk, so persistent, worsening, or unexplained pain should be assessed by a qualified clinician.
This is something to take to a clinician. The Atlas can tell you what is known about trigger point therapy in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Trigger point therapy treats regional muscle pain by finding tender spots, the everyday "knots," and working them with sustained pressure, stretching, or a thin needle (dry needling). The lineage runs deeper and wider than its mid-20th-century American codification suggests: needling tender ashi points in muscle is documented in Chinese medicine more than a thousand years earlier, and 19th-century European physicians described the same palpable muscle bands under names like "muskelschwiele." Janet Travell and David Simons gave the modern field its name, its referred-pain maps, and a mechanistic story, the "integrated trigger point hypothesis," in which a misfiring motor endplate drives a local energy crisis and a self-sustaining muscle contracture. That story is where honesty matters. The clinical syndrome is real and the treatments help some people in the short term, but the existence of the trigger point as a discrete, reliably findable lesion is contested in the literature: there is no agreed test for it, practitioners palpating the same muscle often disagree on where it is, and prominent critics argue the sensation is referred pain from a sensitized nervous system rather than a knot. Enel presents trigger point therapy as a useful clinical practice with modest short-term evidence sitting on a mechanism that remains an open scientific question, and recommends that persistent or worsening pain be evaluated by a qualified clinician.
A familiar idea, the muscle "knot" you can press or needle into release, resting on a clinical finding that is real and a physical entity that the literature has never reliably pinned down.
How it is supposed to work
Established: pressing, stretching, or needling a tender muscle region can produce short-term pain relief and a transient drop in local muscle tension, effects consistent with counter-irritation, local circulatory change, and descending pain modulation common to many manual and needle therapies. Proposed and contested: proponents of the integrated trigger point hypothesis (Simons and successors, originally the 1981 energy crisis model) describe a discrete lesion in which a dysfunctional motor endplate releases excess acetylcholine, a local cluster of sarcomeres contracts and compresses its own capillary supply, oxygen and ATP delivery fall, and the contracture sustains itself, palpable as a taut band with a tender nodule. Critics argue the palpable knot is more economically explained as referred pain from peripheral and central sensitization, with the sarcomere-contracture picture under-evidenced and no agreed reference standard for confirming a trigger point exists at a given spot. The mechanism is therefore genuinely unsettled.
What people get wrong
Often saidA trigger point is a confirmed physical knot that imaging and exams can reliably pinpoint.
ActuallyThere is no agreed test for a trigger point, and clinicians palpating the same muscle frequently disagree on its location; its status as a discrete lesion is contested.
Often saidDry needling is a modern Western innovation distinct from acupuncture.
ActuallyNeedling tender muscle spots descends from East Asian ashi-point practice documented over a millennium earlier; reviewers find trigger points map closely onto ashi points.
Who profits, and who pushes back
David Simons (posthumous, via his published work)
Simons described the trigger point as a discrete, treatable lesion driven by a dysfunctional motor endplate and a local energy crisis, the foundation of the modern field.
American Physical Therapy Association (APTA)
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
APTA presents dry needling of trigger points as a legitimate intervention within physical therapist scope where state law allows, while tracking an uneven state-by-state legal landscape.
John Quintner and Milton Cohen
They argue the trigger point is an unproven construct and that the palpable findings are better explained as referred pain from a sensitized nervous system.
Systematic reviewers of palpation reliability (Lucas and colleagues)
They conclude that physical examination cannot currently be recommended as a reliable test for diagnosing trigger points, given inconsistent inter-rater agreement.
Where the research comes from
Most of the published research on this comes from one place. 90% of it is from United States. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| United States | 90% |
| Western Europe | 75% |
| East Asia (acupuncture/ashi lineage) | 70% |
| Australia & New Zealand | 65% |
| Latin America | 45% |
How we got here
The practice of locating and pressing or needling discrete tender spots in muscle to relieve pain has its oldest documented form in Chinese medicine, where "ashi" points (literally "ah yes," the spot that makes a patient flinch when pressed) were described and needled for centuries before being formalized by the physician Sun Simiao in the Tang dynasty, 7th century CE. Modern reviewers note that nearly all trigger points map onto the ashi class of acupuncture points, tender spots found by palpation rather than fixed channel locations. In 19th-century Europe a parallel vocabulary emerged: the British surgeon William Balfour described painful muscle "thickenings" and "nodular tumours" in 1816, and the German physician Robert Froriep named tender muscle bands "muskelschwiele" (muscle calluses) in 1843. The modern Western codification belongs to the American physicians Janet Travell, a cardiologist and later White House physician to President Kennedy, and David Simons, whose two-volume "Myofascial Pain and Dysfunction: The Trigger Point Manual" (1983) mapped referred-pain patterns and gave the field its diagnostic language. Travell's clinical writing on myofascial pain began in the 1940s; she and Simons formally collaborated from the 1970s.
Treating discrete tender muscle spots is old and cross-cultural. In China, ashi points, tender spots located by pressing rather than by fixed channel position, were needled in classical acupuncture and formalized by the Tang-dynasty physician Sun Simiao in the 7th century CE; modern reviewers note nearly all trigger points correspond to this ashi class. In Europe, William Balfour (Scotland, 1816) described painful muscle nodules and Robert Froriep (Germany, 1843) coined muskelschwiele for tender muscle bands. Janet Travell began writing on myofascial trigger points in the 1940s and drew maps of referred pain, where pain in one muscle is felt elsewhere; she served as White House physician to President Kennedy. From the 1970s she worked with David Simons, and their two-volume Trigger Point Manual (1983) became the field's reference. From the 1980s, dry needling spread among physical therapists, reopening questions about how the practice relates to acupuncture and who is licensed to perform it.
- 7th c. CETang-dynasty physician Sun Simiao formalizes ashi (tender-spot) points in Chinese acupuncture.
- 1843Robert Froriep (Germany) names tender muscle bands 'muskelschwiele' (muscle calluses).
- 1940sJanet Travell begins publishing on myofascial trigger points and referred-pain maps.
- 1983Travell and Simons publish the two-volume Trigger Point Manual, the field's reference text.
- 2015Quintner and Cohen publish a prominent critique in Rheumatology challenging trigger-point theory; dispute remains active.
How it is understood
The needling of tender muscle spots is continuous with East Asian ashi-point acupuncture; Enel names that lineage rather than presenting dry needling as a purely Western invention. No active sovereignty restriction applies to the broad practice, though the relationship between dry needling and licensed acupuncture is a live professional and regulatory dispute.
Where scholars disagree
The clinical finding (regional myofascial pain that responds short-term to treating tender spots) is widely accepted, but the existence and nature of the 'trigger point' as a discrete physical lesion, and the energy-crisis/motor-endplate mechanism, are actively disputed.
Integrated-hypothesis proponents (David Simons and successors; much of the dry-needling and manual-therapy field)
A trigger point is a real, discrete lesion: a hyperirritable spot in a taut band where a dysfunctional motor endplate triggers a self-sustaining local energy crisis and sarcomere contracture, palpable and treatable.
What it rests onTravell and Simons' referred-pain mapping; electromyographic recordings of spontaneous endplate activity at putative trigger points; reproducible referred-pain patterns and 'twitch responses' on needling.
Critics led by John Quintner and Milton Cohen (Rheumatology, 2015), with reliability studies (Lucas and colleagues) and critiques (Mense)
The palpable 'knot' is not a proven discrete lesion; what is felt is better explained as referred pain from peripheral and central sensitization. The energy-crisis model is circular and under-evidenced, and palpation cannot reliably locate the supposed point.
What it rests onSystematic reviews finding poor and inconsistent inter-rater reliability of trigger-point palpation; absence of any agreed reference standard or confirmatory test; logical critique that the construct assumes what it sets out to prove.
This disagreement is live. It has not settled.
At a glance
- Modern codifiers
- Janet Travell and David Simons (US); two-volume Trigger Point Manual, 1983
- Oldest documented antecedent
- Chinese ashi (tender-spot) acupuncture, formalized by Sun Simiao, 7th c. CE
- Core dispute
- Whether trigger points exist as discrete lesions, and whether the energy-crisis mechanism holds
- Diagnostic reliability
- No accepted reference standard; palpation inter-rater reliability is poor in systematic reviews
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Trigger Point Therapy. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.